1-2 of 2
Ying Zheng
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Neoadjuvant Durvalumab Alone or Combined with Novel Immuno-Oncology Agents in Resectable Lung Cancer: The Phase II NeoCOAST Platform Trial

Tina Cascone, Gozde Kar, Jonathan D. Spicer, Rosario García-Campelo, Walter Weder, Davey B. Daniel, David R. Spigel, Maen Hussein, Julien Mazieres, Julio Oliveira, Edwin H. Yau, Alexander I. Spira, Valsamo Anagnostou, Raymond Mager, Oday Hamid, Lin-Yang Cheng, Ying Zheng, Jorge Blando, Tze Heng Tan, Michael Surace, Jaime Rodriguez-Canales, Vancheswaran Gopalakrishnan, Bret R. Sellman, Italia Grenga, Yee Soo-Hoo, Rakesh Kumar, Lara McGrath, Patrick M. Forde
Journal: Cancer Discovery
Cancer Discov (2023) 13 (11): 2394–2411.
https://doi.org/10.1158/2159-8290.CD-23-0436
Published: 01 November 2023
View article titled, Neoadjuvant Durvalumab Alone or Combined with Novel Immuno-Oncology Agents in Resectable Lung Cancer: The Phase II NeoCOAST Platform Trial
Open the PDF for Neoadjuvant Durvalumab Alone or Combined with Novel Immuno-Oncology Agents in Resectable Lung Cancer: The Phase II NeoCOAST Platform Trial in another window
Includes: Supplementary data
Journal Articles

YAP Is Essential for Treg-Mediated Suppression of Antitumor Immunity

Xuhao Ni, Jinhui Tao, Joseph Barbi, Qian Chen, Benjamin V. Park, Zhiguang Li, Nailing Zhang, Andriana Lebid, Anjali Ramaswamy, Ping Wei, Ying Zheng, Xuehong Zhang, Xingmei Wu, Paolo Vignali, Cui-Ping Yang, Huabin Li, Drew Pardoll, Ling Lu, Duojia Pan, Fan Pan
Journal: Cancer Discovery
Series: Author Choice
Cancer Discov (2018) 8 (8): 1026–1043.
https://doi.org/10.1158/2159-8290.CD-17-1124
Published: 02 August 2018
View article titled, YAP Is Essential for Treg-Mediated Suppression of Antitumor Immunity
Open the PDF for YAP Is Essential for Treg-Mediated Suppression of Antitumor Immunity in another window
Includes: Supplementary data